The largest database of trusted experimental protocols

Can get signal pvdf blocking reagent

Manufactured by Toyobo
Sourced in Japan, United Kingdom

Can Get Signal PVDF Blocking Reagent is a laboratory product designed to block non-specific binding on polyvinylidene fluoride (PVDF) membranes. It is used as part of the Western blotting process to improve the signal-to-noise ratio and enhance the detection of target proteins.

Automatically generated - may contain errors

3 protocols using can get signal pvdf blocking reagent

1

Western Blot Analysis of EV Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
EV pellets were lysed in RIPA assay buffer (FUJIFILM Wako Pure Chemical Corporation) for 30 min on ice. Protein samples were electrophoresed on a 10% SDS–polyacrylamide gel and blotted onto polyvinylidene difluoride membranes (Bio-Rad Laboratories, Hercules, CA). The membranes were washed with TBS-Tween and were shaken in Can Get Signal PVDF Blocking Reagent (TOYOBO) at room temperature for 1 h. After washed, the membranes were incubated with primary antibodies diluted in Can Get Signal Solution 1 (TOYOBO) at room temperature for 1 h. After washed, the membrane was incubated with secondary antibodies conjugated to horseradish peroxidase (HRP) diluted in Can Get Signal Solution 2 (TOYOBO) at room temperature for 1 h. After washed, the membranes were incubated with Immobilon Western Chemiluminescent HRP Substrate (Merck Millipore, KGaA, Darmstadt, Germany) for a few seconds, and chemiluminescence was detected using the ChemiDoc Touch system (Bio-Rad). The following antibodies were used: mouse anti-CD63 (Santa Cruz Biotechnology, Santa Cruz, CA) and sheep anti-mouse IgG HRP (Sigma).
+ Open protocol
+ Expand
2

Western Blot Analysis of EGFR, IGF-IR, and AKT

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were lysed in a 1× RIPA Lysis Buffer (EMD Millipore, Burlington, MA) containing a complete Protease Inhibitor Cocktail and PhosSTOP (Roche Applied Science, Penzberg, Germany). Proteins were electrophoresed on 4%–20% Mini-PROTEAN TGX Precast Gels (Bio-Rad, Hercules, CA) and transferred to membranes using a Trans-Blot Turbo Transfer Pack PVDF (Mini) (Bio-Rad). The membranes were blocked with Can Get Signal/PVDF Blocking Reagent (Toyobo, Osaka, Japan) and incubated with primary antibodies overnight using Can Get Signal Solution 1 (Toyobo). After washing three times with Tris-buffered saline containing 0.05% Tween 20, the membranes were incubated with HRP-conjugated anti-rabbit or anti-mouse IgG (Cell Signaling Technology, Danvers, MA) for 1 hour. The membranes were imaged by ChemiDoc XRS Plus (Bio-Rad). The following primary antibodies were used: phosphorylated (p)-epidermal growth factor receptor (EGFR; Tyr1068) (D7A5), EGFR (D38B1), phosphorylated (p)-IGF-I receptor β (Tyr1135/1136)/insulin receptor β (INSRβ; Tyr1150/1151) (19H7), IGF-I receptor β, p-AKT (Ser473), AKT (pan) (11E7), p-SHP-2 (Tyr542), SHP-2 (D50F2), β-actin, and GAPDH (Cell Signaling Technology).
+ Open protocol
+ Expand
3

Western Blot Analysis of RSV-G Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested in a lysis buffer (100 mM Tris-HCl (pH 6.8), 2% SDS, 20% glycerol, 2% β-mercaptoethanol, and 0.4 mg/ml bromophenol blue), and boiled at 100 °C for 10 min. Soluble proteins (25 μg) were separated by SDS-PAGE and transferred to a PVDF membrane (Bio-Rad) by Trans-blot turbo (Bio-Rad). The membrane was immersed with the Can Get Signal PVDF blocking Reagent (Toyobo) for 1 h, and incubated with monoclonal antibodies against RSV-G protein (1:1000, 94966; Abcam, Cambridge, UK) and β-actin (1:5000, A5316; Sigma-Aldrich, St. Louis, Missouri, US) for overnight. After washing with PBS containing 0.1% tween 20, the membrane was blotted with horseradish peroxidase-conjugated secondary antibody followed by visualization with a chemiluminescence agent, ECL Prime Western Blotting Detection Reagent (GE Healthcare, Chicago, Illinois, US) by LAS-3000 (GE Healthcare).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!